Identify patients with iron overload in patients with β-thalassemia

Develop personalized prophylactic treatment plans for patients with hemophilia A.

Describe the factors to consider in promoting shared decision making for stage IV melanoma

An expert-led webinar designed to address the critical need for education about the potential future of neoadjuvant therapy for early-stage NSCLC

IDENTIFY patients with newly diagnosed MM for whom treatment with an anti-CD38 monoclonal antibody-based therapeutic regimen would be appropriate

Explore the clinical evidence surrounding the role of HER3 in various tumor types.

Outline how new or emerging options may fit into existing treatment algorithms for patients with uveal melanoma.

This activity provides an overview of molecular and clinical subtypes of lymphoma and the mechanisms by which targeted therapies work for molecular subtypes.